Gyre Therapeutics
GYRE
#5828
Rank
C$1.23 B
Marketcap
$14.41
Share price
3.85%
Change (1 day)
-55.31%
Change (1 year)

Operating Margin for Gyre Therapeutics (GYRE)

Operating Margin as of January 2025 (TTM): 16.93%

According to Gyre Therapeutics's latest financial reports and stock price the company's current Operating Margin is 16.93%. At the end of 2023 the company had an Operating Margin of 16.94%.

Operating Margin history for Gyre Therapeutics from 2022 to 2024

202320242025-60 %-40 %-20 %20 %40 %0companiesmarketcap.com

Operating Margin at the end of each year

Year Operating Margin Change
202316.94%88.23%
20229.00%-72.89%
202133.18%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.